Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria

Future Microbiology

Volumn 4, Issue 4, 2009, Pages 441-455

  Roepe, Paul D ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Digestive vacuole; Hemozoln; Multidrug resistance; Plasmodium falciparum chloroquine resistance transporter

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMODIAQUINE; ARTEMISIN; ARTEMISININ DERIVATIVE; CHLOROQUINE; CYCLOGUANIL; ENDOPEROXIDE; FOLIC ACID ANTAGONIST; MEFLOQUINE; MICROORGANISM PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN CG2; PROTEIN CRT; PYRIMETHAMINE; QUINIDINE; QUININE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; QUINOLINE; QUINOLINE DERIVATIVE;

ANTIMALARIAL DRUG RESISTANCE; BIOCHEMISTRY; CELL FUNCTION; CYTOTOXICITY; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE MUTATION; MALARIA FALCIPARUM; MOLECULAR GENETICS; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; ANIMAL; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; PARASITOLOGY;

PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; QUINOLINES;

EID: 66949146530     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.15     Document Type: Review

References (100)

1. Geary TG, Jensen JB, Ginsburg H: Uptake of (3H)chloroquine by drug sensitive and resistant strains of the human malaria parasite Plasmodium falciparum. Biochem. Pharmacol. 35, 3805-3812 (1986).
2. Bray PG, Hawley SR, Mungthin M, Ward SA: Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol. Pharmacol. 50, 1559-1566 (1996).
3. O'Neill PM, Bray PG, Hawley SR, Ward SA, Park BK: 4-aminoquinolines-past, present and future: a chemical perspective: Pharmacol. Ther. 77, 29-58 (1998).
4. Krogstad DJ, Schlesinger PH: The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH. J. Trop. Med. Hygiene 36, 213-220 (1987).
5. Egan TJ: Interactions of quinoline antimalarials with hematin in solution. J. Inorg. Biochem. 100(5-6), 916-926 (2006).
6. Ursos LMB, Roepe PD: Recent progress in elucidating the molecular mechanism of resistance to the antimalarial drug chloroquine. Med. Res. Rev. 22(5), 465-491 (2002).
7. Scholl PF, Tripathi AK, Sullivan DJ: Bioavailable iron and heme metabolism in Plasmodium falciparum. Curr. Top. Microbiol. Immunol. 295, 293-324 (2005).
8. Bray PG, Ward SA: A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum. Pharmacol. Ther. 77, 1-28 (1998).
9. Bray PG, Mungthin M, Ridley RG, Ward SA: Access to hematin: the basis of chloroquine resistance. Mol. Pharmacol. 54, 170-179 (1998).
10. Chong CR, Sullivan DJ Jr: Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery. Biochem. Pharmacol. 66(11), 2201-2212 (2003).
11. Cohen SN, Phifer KO, Yielding KL: Complex formation between chloroquine and ferrihaemic acid in vitro, and its effect on the antimalarial action of chloroquine. Nature 202, 805-806 (1964).
12. Fitch CD: Chloroquine resistance in malaria: a deficiency of chloroquine binding. Proc. Natl Acad. Sci. USA 64(4), 1181-1187 (1969).
13. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK: The structure of malaria pigment β-haematin. Nature 404(6775), 307-310 (2000).
14. Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG: An assessment of drug-haematin polymerisation by quinoline antimalarias. Biochem. Pharmacol. 55, 727-736 (1998).
15. Gligorijevic B, McAllister R, Urbach JS, Roepe PD: Spinning disk confocal microscopy of live, intraerythrocytic malarial parasites, 1. Quantification of hemozoin development for drug sensitive versus resistant malaria. Biochemistry 45(41), 12400-12410 (2006).
16. Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley RG: Malarial hemazoin/ β-hematin supports heme polymerization in the absence of protein. Nature 374, 269-271 (1995).
17. Sullivan DJ Jr, Gluzman IY, Russell DG, Goldberg DE: On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl Acad. Sci. USA 93, 11865-11870 (1996).
18. Leed A, DuBay K, Ursos LMB, Sears D, de Dios AC, Roepe PD: Solution structures of antimalarial drug/heme complexes. Biochemistry 41, 10245-10255 (2002).
19. de Dios AC, Casabianca LB, Kosar A, Roepe PD: Structure of the amodiaquine - FPIX μ oxo dimer solution complex at atomic resolution. Inorg. Chem. 43(25), 8078-8084 (2004).
20. de Dios AC, Tycko R, Ursos LMB, Roepe PD: NMR Studies of chloroquine-ferriprotoporphyrin IX complex. J. Phys. Chem. A 107, 5821-5825 (2003).
21. Bennett TN, Kosar AD, Ursos LMB et al.: Acidic digestive vacuolar pH of drug resistant Plasmodium falciparum. Mol. Biochem. Parasitol. 133, 99-114 (2004).
22. Gligorijevic B, Bennett T, McAllister R, Urbach JS, Roepe PD: Spinning disk confocal microscopy of live, intraerythrocytic malarial parasites. 2. Altered vacuolar volume regulation in drug resistant malaria. Biochemistry 45(41), 12411-12423 (2006).
23. Roepe PD, Martiney JA: Are ion exchange processes central to understanding drug resistance phenomena? Trends Pharmacol. Sci. 20, 62-65 (1998).
24. Pisciotta JM, Coppens I, Tripathi AK et al.: The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem. J. 402(1), 197-204 (2007).
25. Jackson KE, Klonis N, Ferguson DJ, Adisa A, Dogovski C, Tilley L: Food vacuole-associated lipid bodies and heterogeneous lipid environments in the malaria parasite, Plasmodium falciparum. Mol. Microbiol. 54(1), 109-122 (2004).
26. Casabianca LB, An D, Natarajan JK et al.: Quinine and chloroquine differentially perturb heme monomer-dimer equilibrium. Inorg. Chem. 47(13), 6077-6081 (2008).
27. Casabianca LB, Kallgren JB, Natarajah JK et al.: Antimalami drugs and heme in detergent micelles: an NMR study. J. Inorg. Biochem. (2009).
28. Gligorijevic B, Purdy K, Elliott DA, Cooper RA, Roepe PD: Stage independent chloroquine resistance and chloroquine toxicity revealed via spinning disk confocal microscopy. Mol. Biochem. Parasitol. 159 (1), 7-23 (2008).
29. Elliott DA, McIntosh MT, Hosgood HD et al.: Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum. Proc. Natl Acad. Sci. USA 105(7), 2463-2468 (2008).
30. Francis SE, Sullivan DJ Jr, Goldberg DE: Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51, 97-123 (1997).
31. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM: Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359(24), 2619-2620 (2008).
32. Bray PG, Hawley SR, Ward SA: 4-aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake. Mol. Pharmacol. 50, 1551-1558 (1996).
33. Martiney JA, Cerami A, Slater AFG: Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect. J. Biol. Chem. 270, 22393-22398 (1995).
34. Vargas RC, Garcia-Salcedo R, Tenreiro S et al.: Saccharomyces cerevisiae multidrug resistance transporter Qdr2 is implicated in potassium uptake, providing a physiological advantage to quinidine-stressed cells. Eukaryot. Cell 6(2), 134-142 (2007).
35. Dzekunov S, Ursos L, Roepe PD: Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chioroquine. Mol. Biochem. Parasitol. 110, 107-124 (2000).
36. Hoffman MM, Roepe PD: Analysis of ion transport perturbations caused by hu MDR 1 protein overexpression. Biochemistry 36, 11153-11168 (1997).
37. + antiporter that is physiologically important at elevated pH. J. Biol. Chem. 269, 27365-27371 (1994).
38. Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, Wirth DF: Amplification of a gene related to mammalian. mdr genes in drug-resistant Plasmodium falciparum. Science 244, 1184-1186 (1989).
39. Foote SJ, Thompson JK, Cowman AF, Kemp DJ: Amplification of the mulidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57, 921-930 (1989).
40. Wellems TE, Panton LJ, Gluzman IY et al.: Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345, 253-255 (1990).
41. Barnes DA, Foote SJ, Galatis D, Kemp DJ, Cowman AF: Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J. 11, 3067-3075 (1992).
42. Roepe PD, Wei L-Y, Cruz J, Carlson D: Lower electrical membrane potential and altered pHi homeostasis in multidrug resistant cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochemistry 32, 11042-11056 (1993).
43. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74(6), 957-967 (1993).
44. den Boer ML, Pieters R, Kazemier KM et al.: Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. Blood 91(6), 2092-2098 (1998).
45. Su X, Kirkman LA, Fujioka H, Wellems TE: Complex polymorphisms in an 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91, 593-603 (1997).
46. Wellems TE, Walker-Jonah A, Panton LJ: Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc. Natl Acad. Sci. USA 88(8), 3382-3386 (1991).
47. + exchanger determines chloroquine uptake in Plasmodium falciparum. J. Cell Biol. 140, 335-345 (1998).
48. + exchanger of Plasmodium falciparum? Cell 92, 601-602 (1998).
49. + exchangers. Cell 94, 285-286 (1998).
50. Cooper RA, Papakrivos J, Lane KD, Fujioka H, Lingelbach K, Wellems TE: PfCG2, a Plasmodium falciparum protein peripherally associated with the parasitophorous vacuolar membrane, is expressed in the period of maximum hemoglobin uptake and digestion by trophozoites. Mol. Biochem. Parasitol. 144(2), 167-176 (2005).
51. Bray PG, Janneh O, Raynes KJ, Mungthin M, Ginsburg H, Ward SA: Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. J. Cell Biol. 145, 363-376 (1999).
52. + exchange activity is correlated with quinine resistance. Mol. Biochem. Parasitol. 153, 48-58 (2007).
53. Fidock DA, Nomura T, Cooper RA, Su X, Talley AK, Wellems TE: Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum. Mol. Biochem. Parasitol. 110(1), 1-10 (2000).
54. Martiney JA, Ferrey AS, Cerami A, Dzekuhov S, Roepe PD: Chloroquine uptake, altered partitioning and the basis of drug resistance: evidence for a role of chloride-dependent ionic regulation. In: Transport and trafficking in the malaria infected erythrocyte. Wiley, Winchester, UK, 265-281 (1999).
55. Fidock DA, Nomura T, Talley AK et al.: Mutations in the digestive vacuole transmembrane proteins pfcrt and evidence for their role in chloroquine resistance. Mol. Cell. 6, 861-871 (2000).
56. Sidhu AB, Verdier-Pinard D, Fidock DA: Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298, 210-213 (2002).
57. Cooper RA, Ferdig MT, Su X et al.: Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT produce chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol. Pharmacol. 61, 1-8 (2002).
58. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF: Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403, 906-909 (2000).
59. Sidhu AB, Valderramos SG, Fidock DA: pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57(4), 913-926 (2005).
60. Ferdig MT, Cooper RA, Mu J et al.: Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52(4), 985-997 (2004).
61. Krogstad DJ, Gluzman IY, Kyle DE et al.: Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238, 1283-1285 (1987).
62. Barnes DA, Foote SJ, Galatis D, Kemp DJ, Cowman AF: Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J. 11, 3067-3075 (1992).
63. Foote SJ, Kyle DE, Martin RK et al.: Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345, 255-258 (1990).
64. Mehlotra RV, Fujioka H, Roepe PD et al.: Evolution of new Plasmodium falciparum chloroquine resistance phenotype in association with pfcrt polymorphisms in Papua New Guinea and South America. Proc. Natl Acad. Sci. USA 98(22), 12689-12694 (2001).
65. Chen N, Kyle DE, Pasay C et al.: Pfcrt allelic types with two novel amino-acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Phillipines. Antimicrob. Agents Chemother. 47(11), 3500-3505 (2003).
66. Lim P, Chy S, Ariey F et al.: Pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob. Agents Chemother. 47(11), 87-94 (2003).
67. Cowman AF, Galatis D, Thompson JK: Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl Acad. Sci. USA 91, 1143-1147 (1994).
68. Ritchie GY, Mungthin M, Green JE, Bray PG, Hawley SR, Ward SA: In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1. Mol. Biochem. Parasitol. 83, 35-46 (1996).
69. Dorsey G, Kamya MR, Singh A, Rosenthal PJ: Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr1 genes and clinical response to chloroquine in Kampala, Uganda, J. Infec. Dis. 183, 1417-1420 (2001).
70. Price RN, Uhlemann AC, Brockman A et al.: Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364 (5432), 438-447 (2004).
71. Ursos L, Dzekunov S, Roepe PD: The effects of chloroquine and verapamil on digestive vacuolar pH of P. falciparum either sensitive or resistant to chloroquine. Mol. Biochem. Parasitol. 110, 125-134 (2000).
72. Zhang H, Howard EM, Roepe PD: Analysis of the antimalarial drug resistance protein PfCRT expressed in yeast. J. Biol. Chem. 277, 49767-49775 (2002).
73. Zhang H, Paguio M, Roepe PD: The antimalarial drug resistance protein Plasmodium falciparum chloroquine resistance transporter binds chloroquine. Biochemistry 43(26), 8290-8296 (2004).
74. Naude B, Brzostowski JA, Kimmel AR, Wellems TE: Dictyostelium discoideum expresses a malaria chloroquine resistance mechanism upon transfection with mutant, but not wild-type, Plasmodium falciparum transporter PfCRT. J. Biol. Chem. 280 (27), 25596-25603 (2005).
75. Johnson DJ, Fidock DA, Mungthin M et al.: Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell. 15(6), 867-877 (2004).
76. Reeves DC, Liebelt DA, Lakshmanan V, Roepe PD, Fidock DA, Akabas MH: Chloroquine-resistant isoforms of the Plasmodium falciparum chloroquine resistance transporter acidify lysosomal pH in HEK293 cells more than chloroquine-sensitive isoforms. Mol. Biochem. Parasitol. 150(2), 288-299 (2006).
77. + antiport of Plasmodium falciparum membrane. J. Cell. Physiol. 154(3), 527-534 (1993).
78. + exchanger. Mol. Biochem. Parasitol. 162(1), 96-99 (2008).
79. + exchanger (PfNHE) hxnctxon and quinine resistance (QNR). Mol. Biochem. Parasitol. 166, 1-2 (2009).
80. Karcz SR, Herrmann VR, Trottein F, Cowman AF: Cloning and characterization of the vacuolar ATPase B subunit from Plasmodium falciparum. Mol. Biochem. Parasitol. 65(1), 123-133 (1984).
81. Hayward R, Saliba KJ, Kirk K: The pH of the digestive vacuole of Plasmodium falciparum is not associated with-chloroquine resistance. J. Cell Sci. 119(Pt 6), 1016-1025 (2006).
82. Dzekunov S, Ursos L, Roepe PD: Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol. Biochem. Parasitol. 110, 107-124 (2000).
83. Nessler S, Friedrich O, Bakouh N et al.: Evidence for activation of endogenous transporters in Xenopus laevis oocytes expressing the Plasmodium falciparum chloroquine resistance transporter, PfCRT. J. Biol. Chem. 279(38), 39438-39446 (2004).
84. Klonis N, Tan O, Jackson K, Goldberg D, Klemba M, Tilley L: Evaluation of pH during cytostomal endocytosis and vacuolar catabolism of haemoglobin in Plasmodium falciparum. Biochem. J. 407(3), 343-354. (2007).
85. Pan W, Ravot E, Tolle R et al.: Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells. Nucleic Acids Res. 27(4), 1094-1103 (1999).
86. Sanchez CP, McLean JE, Rohrbach P, Fidock DA, Stein WD, Lanzer M: Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 44(29), 9862-9870 (2005).
87. Sanchez CP, Rohrbach P, McLean JE, Fidock DA, Stein WD, Lanzer M: Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum. Mol. Microbiol. 64(2), 407-420 (2007).
88. Amoah LE, Lekostaj JK, Roepe PD: Heterologous expression and ATPase activity of mutant versus wild type PfMDR1 protein. Biochemistry 46(20), 6060-6073 (2007).
89. Lekostaj JK, Amoah LE, Roepe PD: A single S1034C mutation confers altered drug sensitivity to PfMDR1 ATPase activity that is characteristic of the 7G8 isoform. Mol. Biochem. Parasitol. 157(1), 107-111 (2008).
90. Lekostaj JK, Natarajan JK, Paguio MF, WolfC, Roepe PD: Photoaffinity labeling of the Plasmodium falciparum chloroquine resistance transporter with a novel perfluorophenylazido chloroquine. Biochemistry 47(39), 10394-10406 (2008).
91. Ekoue-Kovi K, Yearick K, Iwaniuk DP et al.: Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas. Bioorg. Med. Chem. 17(1), 270-283 (2009).
92. Cabrera M, Paguio M, Natarajan JK, Wolf C, Roepe PD: Chloroquine transport in chloroquine resistant Plasmodium falciparum: influx and efflux kinetics using a fluorescent chloroquine probe. Presented at: American Society of Tropical Medicine, Hygiene Annual Meeting. Philadelphia, PA, USA, 4-8 November 2007.
93. Certain LK, Briceño M, Kiara SM, Nzila AM, Watkins WM, Sibley CH: Characteristics of Plasmodium falciparum dbfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987-2006. J. Infect. Dis. 197(12), 1743-1751 (2008).
94. Natarajan JK, Alumasa JN, Yearick K et al.: 4-N-, 4-S-, and 4-O-chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity vs chloroquine resistant malaria. J. Med. Chem. 51(12), 3466-3479 (2008).
95. Yearick K, Ekoue-Kovi K, Iwaniuk DP et al.: Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines J. Med. Chem. 51(7), 1995-1998 (2008).
96. Vivas L, Rattray L, Stewart L et al.: Antimalarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo. Acta Trop. 105(3), 222-228 (2008).
97. Muangnoicharoen S, Johnson DJ, Looareesuwan S, Krudsood S, Ward SA: Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro. Antimicrob. Agents Chemother. 53(4), 1362-1366 (2009).
98. Davis CB, Bambal R, Moorthy GS et al.: Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4-aminoquinoline antimalarials. J. Pharm. Sci. 98(1), 362-377 (2009).
99. Kelly JX, Winter R, Peyton DH, Hinrichs DJ, Riscoe M: Optimization of xanthones for antimalarial activity: the 3,6-bis-ω-diethylaminoalkoxyxanthone series. Antimicrob. Agents Chemother. 46(1), 144-150 (2002).
100. Nkrumah LJ, Riegelhaupt PM, Moura P et al.: Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE. Mol. Biochem. Parasitol. 165, 122-131 (2009).